0001389050false00013890502020-07-292020-07-29

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 29, 2020

Commission File Number 001-33666

ARCHROCK, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

74-3204509

(State or other jurisdiction of incorporation)

(I.R.S. Employer Identification No.)

9807 Katy Freeway, Suite 100, Houston, TX 77024

(Address of principal executive offices, zip code)

(281) 836-8000

Registrant’s telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of exchange on which registered

Common stock, $0.01 par value per share

AROC

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously disclosed in Archrock, Inc.’s (“Archrock”) Current Report on Form 8-K filed with the Securities and Exchange Commission (the “Commission”) on June 24, 2019, Archrock entered into a Board Representation Agreement (“Board Representation Agreement”) with a portfolio company of JDH Capital Company (together with its affiliates, “JDH”), pursuant to which JDH has the right to designate one director to Archrock’s board of directors (the “Board”) for so long as JDH or its successors (together with all affiliates of such person) continue to hold, on an aggregate basis, at least 7.5% of the then-issued and outstanding shares of Archrock’s common stock.

On July 29, 2020, Jeffery D. Hildebrand, who was previously appointed to the Board pursuant to the Board Representation Agreement, notified Archrock of his resignation from the Board. Mr. Hildebrand informed the Board that his resignation was not due to any disagreement with Archrock or any matter relating to its operations, policies or practices.

In addition, on July 29, 2020, Jason C. Rebrook was appointed to the Board pursuant to the Board Representation Agreement to fill the vacancy resulting from Mr. Hildebrand’s resignation. Mr. Rebrook’s addition to the Board is effective as of July 29, 2020.

From time to time, Archrock provides compression services to certain affiliates of Mr. Rebrook.  For the fiscal year ended December 31, 2019, affiliates of Mr. Rebrook paid an aggregate of approximately $31.4 million to affiliates of Archrock in exchange for compression and related services.

Other than the Board Representation Agreement, there are no arrangements or understandings between Mr. Rebrook and any other person pursuant to which he was elected as a director.  Further, other than as disclosed herein, there are no transactions between Mr. Rebrook or any member of his immediate family and Archrock or any of its subsidiaries that would be reportable as a related party transaction under the rules of the Commission.

Mr. Rebrook has not been appointed to any committee of the Board.

Further, pursuant to the Board Representation Agreement, Mr. Rebrook will not receive any compensation for his service as a director of Archrock.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ARCHROCK, INC.

By:

/s/ Stephanie C. Hildebrandt

Stephanie C. Hildebrandt

Senior Vice President, General Counsel and
Secretary

July 30, 2020

3

v3.20.2
Document and Entity Information
Jul. 29, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jul. 29, 2020
Entity File Number 001-33666
Entity Registrant Name ARCHROCK, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 74-3204509
Entity Address, Address Line One 9807 Katy Freeway
Entity Address, Adress Line Two Suite 100
Entity Address, City or Town Houston
Entity Address, State or Province TX
Entity Address, Postal Zip Code 77024
City Area Code 281
Local Phone Number 836-8000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $0.01 par value per share
Trading Symbol AROC
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001389050
Amendment Flag false